257 related articles for article (PubMed ID: 2886348)
1. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
[TBL] [Abstract][Full Text] [Related]
5. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
Reggiani A; Carenzi A; Frigeni V; Della Bella D
Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
[TBL] [Abstract][Full Text] [Related]
6. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
[TBL] [Abstract][Full Text] [Related]
7. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
Hazato T; Kase R; Ueda H; Takagi H; Katayama T
Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
[TBL] [Abstract][Full Text] [Related]
9. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative.
Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP
Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
Shimamura M; Kawamuki K; Hazato T
J Neurochem; 1987 Aug; 49(2):536-40. PubMed ID: 3037031
[TBL] [Abstract][Full Text] [Related]
11. Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors.
Zhang AZ; Yang HY; Costa E
Neuropharmacology; 1982 Jul; 21(7):625-30. PubMed ID: 6750433
[TBL] [Abstract][Full Text] [Related]
12. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
[TBL] [Abstract][Full Text] [Related]
13. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
14. Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides.
Shimamura M; Hazato T; Iwaguchi T
J Biochem; 1991 Mar; 109(3):492-7. PubMed ID: 1679058
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum.
van Amsterdam JG; van Buuren KJ; Krielaart MJ; Zuiderveld OP; Tijms RP
Life Sci; 1988; 43(19):1529-36. PubMed ID: 3193845
[TBL] [Abstract][Full Text] [Related]
16. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum.
Aoki K; Kajiwara M; Oka T
Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902
[TBL] [Abstract][Full Text] [Related]
17. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of enkephalin degradation by phelorphan: effects on striatal [Met5]enkephalin levels and jump latency in mouse hot plate test.
Van Amsterdam JG; Llorens-Cortes C
Eur J Pharmacol; 1988 Sep; 154(3):319-24. PubMed ID: 3234484
[TBL] [Abstract][Full Text] [Related]
19. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of peptidases potentiates enkephalin-stimulated contraction of gastric muscle cells.
Menozzi D; Gu ZF; Maton PN; Bunnett NW
Am J Physiol; 1991 Sep; 261(3 Pt 1):G476-84. PubMed ID: 1679601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
